Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.

Kvasnicka, H M

Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 2001 - 2994-3009 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0732-183X

10.1200/JCO.2001.19.12.2994 doi


Antineoplastic Agents--therapeutic use
Bone Marrow--pathology
Decision Trees
Female
Humans
Hydroxyurea--therapeutic use
Interferon alpha-2
Interferon-alpha--therapeutic use
Leukemia, Myeloid, Chronic-Phase--classification
Lymphocyte Activation
Macrophages--pathology
Male
Megakaryocytes--pathology
Middle Aged
Multivariate Analysis
Primary Myelofibrosis--pathology
Prognosis
Recombinant Proteins
Regression Analysis
Reproducibility of Results
Risk
Sensitivity and Specificity
Survival Analysis